Adma Biologics ADMA
NASDAQ ADMA
$9.93 -0.10 (-1.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Net Equity Issued and Repurchased (2011 - 2026)

Updated

Adma Biologics' Net Equity Issued and Repurchased was $35,000 in Q2 2026, down 98.3% from $2.06 million a year earlier and down 94.0% from the prior quarter.

Analysis

Adma Biologics (ADMA) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Adma Biologics' Net Equity Issued and Repurchased was $1.44 million through Jun 30, 2026, down 82.6% year-over-year; for FY2025, it was $2.98 million, down 60.2% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -53.1% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $7.49 million in FY2024 (+578.8%), $1.1 million in FY2023 (-98.3%), $64.65 million in FY2022 (-46.6%) and $121.14 million in FY2021 (-7.7%).
  • The Q2 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q4 2023.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in three of the last seven quarters, with growth averaging 219.0%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2024 (growth of 812.0%); the worst was Q4 2023 (a decline of 100.0%).
  • Per Business Quant data, ADMA's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $588,000 (Q1 2026), $430,000 (Q4 2025) and $389,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Adma Biologics 2.26 Bn 1.84 Bn 86.28 Mn 35,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35,000.00
Mar 31, 2026 588,000.00
Dec 31, 2025 430,000.00
Sep 30, 2025 389,000.00
Jun 30, 2025 2.06 Mn
Mar 31, 2025 101,000.00
Dec 31, 2024 443,000.00
Sep 30, 2024 5.69 Mn
Jun 30, 2024 331,000.00
Mar 31, 2024 1.03 Mn
Dec 31, 2023 8,000.00
Sep 30, 2023 624,000.00
Jun 30, 2023 472,000.00
Dec 31, 2022 64.65 Mn
Dec 31, 2021 53.83 Mn
Sep 30, 2021 8.21 Mn
Jun 30, 2021 17.19 Mn
Mar 31, 2021 41.91 Mn
Dec 31, 2020 31.85 Mn
Sep 30, 2020 10.64 Mn
API Access

Adma Biologics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ADMA&period=max&api_key=YOUR_API_KEY